Hiroshi R. Seno
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 322 publications
Anti-integrin αvβ6 autoantibodies in ulcerative colitis
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: July 12, 2026
High-Altitude Renal-Metabolic Stress and Albuminuria in Hospitalized Patients With Diabetes in Tibet.
Journal: Geriatrics & gerontology international
Published: June 25, 2026
The Warburg effect provides attributes that facilitate tumor-cell resistance.
Journal: Histology and histopathology
Published: June 18, 2026
Azathioprine-Induced Acute Sialadenitis and Pancreatitis in a Patient With Ulcerative Colitis.
Journal: Internal medicine (Tokyo, Japan)
Published: June 10, 2026
The Association Between Tongue Pressure and Body Mass Index, Lower-Limb Muscle Strength, and Muscle Mass in Community-Dwelling Older Adults.
Journal: Cureus
Published: May 26, 2026
Submucosal Lidocaine Injection in Colonic Endoscopic Submucosal Dissection: A Single-Center, Double-Blind, Randomized Controlled Trial.
Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
Published: April 30, 2026
Corrigendum to Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer.
Journal: The Journal of clinical investigation
Published: April 01, 2026
Anti-Integrin αvβ6 Autoantibodies as Diagnostic and Monitoring Biomarkers for Pediatric-Onset Primary Sclerosing Cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 11, 2026
Reply to "Interpreting risk scores after gastric ESD: insights from recent validation".
Journal: Journal of gastroenterology
Published: February 20, 2026
Reply to "Performance of risk models in predicting outcomes of atezolizumab and bevacizumab therapy".
Journal: Journal of gastroenterology
Published: February 20, 2026
Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.
Journal: Liver cancer
Published: February 06, 2026
Last Updated: 09/26/2026